Kaleido Biosciences, Inc.
KLDO · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38 | $56 | $72 | $92 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $5 | $3 | $3 |
| Total Curr. Assets | $42 | $56 | $75 | $95 |
| Property Plant & Equip (Net) | $6 | $7 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $5 | $2 | $2 |
| Total NC Assets | $8 | $12 | $10 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $50 | $68 | $84 | $105 |
| Liabilities | – | – | – | – |
| Payables | $6 | $4 | $3 | $2 |
| Short-Term Debt | $16 | $6 | $4 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $9 | $6 | $5 |
| Total Curr. Liab. | $30 | $19 | $12 | $13 |
| LT Debt | $6 | $15 | $18 | $16 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $4 | $4 | $4 |
| Total NC Liab. | $10 | $19 | $22 | $20 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $40 | $39 | $34 | $33 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$364 | -$344 | -$321 | -$297 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $375 | $373 | $371 | $369 |
| Total Equity | $11 | $29 | $50 | $72 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $50 | $68 | $84 | $105 |
| Net Debt | -$17 | -$34 | -$51 | -$71 |